| 0.3 |
0.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.2 |
0.6 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.2 |
1.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.7 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.2 |
1.1 |
GO:1902748 |
positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 |
0.5 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.5 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 |
0.4 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
1.0 |
GO:0007527 |
adult somatic muscle development(GO:0007527) |
| 0.1 |
0.4 |
GO:1904766 |
negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
| 0.1 |
0.7 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 |
0.4 |
GO:0032741 |
positive regulation of interleukin-18 production(GO:0032741) |
| 0.1 |
0.7 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 0.1 |
0.5 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.5 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 |
0.6 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
1.1 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.6 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.4 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 |
0.4 |
GO:0002859 |
negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.1 |
0.5 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.1 |
0.4 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.3 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.5 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.4 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.3 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.3 |
GO:0003032 |
detection of oxygen(GO:0003032) cardiac jelly development(GO:1905072) |
| 0.1 |
0.6 |
GO:0070495 |
regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 |
0.6 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.6 |
GO:0002278 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.1 |
0.3 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.1 |
0.5 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
1.0 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.4 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.4 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.2 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.1 |
0.4 |
GO:0035128 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.1 |
0.3 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 |
0.1 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
1.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.2 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.2 |
GO:1904172 |
positive regulation of bleb assembly(GO:1904172) |
| 0.1 |
0.1 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.4 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.1 |
0.3 |
GO:0021502 |
neural fold elevation formation(GO:0021502) |
| 0.1 |
0.4 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.4 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.3 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.5 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.2 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.1 |
1.1 |
GO:0045714 |
regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 |
0.4 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.5 |
GO:0001798 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
0.3 |
GO:0070671 |
response to interleukin-12(GO:0070671) cellular response to peptidoglycan(GO:0071224) |
| 0.1 |
0.2 |
GO:0002663 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.1 |
0.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.2 |
GO:0002017 |
regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.1 |
0.6 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.2 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.0 |
0.2 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:0002344 |
peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.3 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.0 |
0.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.2 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.5 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.2 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.0 |
0.1 |
GO:0060983 |
epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
| 0.0 |
0.5 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.5 |
GO:2000580 |
regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.0 |
0.2 |
GO:0002461 |
tolerance induction dependent upon immune response(GO:0002461) |
| 0.0 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.0 |
0.1 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.0 |
0.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.4 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.0 |
0.1 |
GO:1904633 |
glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
| 0.0 |
0.2 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 |
0.2 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.0 |
0.0 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.2 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.0 |
0.2 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.0 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.5 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.2 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.1 |
GO:0061723 |
glycophagy(GO:0061723) |
| 0.0 |
0.1 |
GO:0072023 |
ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
| 0.0 |
0.4 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.0 |
GO:0060733 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.0 |
0.5 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.2 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 |
0.1 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of renal output by angiotensin(GO:0002019) |
| 0.0 |
0.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.9 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:0046049 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.2 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.3 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.0 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.1 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.0 |
0.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.5 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.1 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.0 |
0.1 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.0 |
0.1 |
GO:1900062 |
regulation of replicative cell aging(GO:1900062) |
| 0.0 |
0.1 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.0 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.1 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 |
0.2 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.0 |
0.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.0 |
0.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.0 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) regulation of Rap protein signal transduction(GO:0032487) negative regulation of integrin activation(GO:0033624) |
| 0.0 |
0.1 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.0 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.1 |
GO:0072143 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.0 |
0.1 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 0.0 |
0.1 |
GO:0044010 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.0 |
0.3 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.0 |
0.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.2 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.4 |
GO:0032674 |
regulation of interleukin-5 production(GO:0032674) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:0061356 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 |
0.1 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.0 |
0.2 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.0 |
0.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.1 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.0 |
0.1 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.0 |
0.1 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.0 |
0.1 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.0 |
0.1 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.2 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.0 |
0.1 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.0 |
0.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.0 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.0 |
0.1 |
GO:2000019 |
negative regulation of male gonad development(GO:2000019) |
| 0.0 |
0.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.3 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:1903849 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.0 |
0.1 |
GO:0097535 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.0 |
0.1 |
GO:1900477 |
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
| 0.0 |
0.1 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 0.0 |
0.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.3 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.0 |
0.1 |
GO:0071043 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.5 |
GO:0002251 |
organ or tissue specific immune response(GO:0002251) |
| 0.0 |
0.2 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 |
0.1 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.0 |
1.6 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.1 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.2 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.4 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.0 |
GO:1901003 |
negative regulation of fermentation(GO:1901003) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.0 |
0.8 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.0 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) floor plate morphogenesis(GO:0033505) |
| 0.0 |
0.3 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.0 |
0.2 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.1 |
GO:0051581 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 |
1.1 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.2 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.1 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 0.0 |
0.0 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.0 |
0.3 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.2 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.0 |
0.1 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.0 |
GO:0061623 |
UDP-glucose metabolic process(GO:0006011) glycolytic process from galactose(GO:0061623) |
| 0.0 |
0.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 |
0.0 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.0 |
0.0 |
GO:1904349 |
positive regulation of eating behavior(GO:1904000) positive regulation of small intestine smooth muscle contraction(GO:1904349) |
| 0.0 |
0.1 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.1 |
GO:0035660 |
MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.3 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 |
0.0 |
GO:0007225 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.0 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.6 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.2 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.2 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.2 |
GO:1904259 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.2 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 |
0.1 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.1 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.0 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.2 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.1 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.8 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.0 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.1 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.0 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
| 0.0 |
0.0 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) regulation of cardiac ventricle development(GO:1904412) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.0 |
0.0 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
| 0.0 |
0.0 |
GO:0060464 |
lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
| 0.0 |
0.0 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
16.9 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.0 |
0.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
0.3 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
0.8 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.1 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.0 |
0.1 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.0 |
0.2 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |